Concomitant vaccination during during study protocol period | except for study vaccination
Item
Has any vaccine other than the study vaccine(s) been administered during the period between Visit 1 and Visit 6?
boolean
C0042196 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C1948053 (UMLS CUI [1,4])
C2348563 (UMLS CUI [1,5])
C1705847 (UMLS CUI [2,1])
C0042196 (UMLS CUI [2,2])
C3854006 (UMLS CUI [2,3])
Trade name | generic name concomitant vaccination
Item
Trade/generic name
text
C2360065 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
C0592502 (UMLS CUI [2,1])
C0042196 (UMLS CUI [2,2])
C2347852 (UMLS CUI [2,3])
Item
Route of administration
text
C0013153 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
Code List
Route of administration
CL Item
Intramuscular (IM)
CL Item
Subcutaneous (SC)
Date of administration concomitant vaccination
Item
Administration date
date
C0011008 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,3])
Clinical study sponsor comment
Item
For GSK
text
C2347796 (UMLS CUI [1,1])
C0947611 (UMLS CUI [1,2])